You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aldehyde Dehydrogenase

Showing 51 - 75 of 281
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Natural History Study of Pyruvate Dehydrogenase Deficiency

Recruiting
  • Pyruvate Dehydrogenase Complex Deficiency
  • +4 more
    • London, United Kingdom
      Great Ormond Street Hospital
    Feb 16, 2022

    Leukemia, Leukemia, Myeloid, Monocytic Leukemia Trial in Palo Alto (Enasidenib mesylat dose escalation)

    Recruiting
    • Leukemia
    • +2 more
    • Enasidenib mesylat dose escalation
    • Palo Alto, California
      Stanford Cancer Institute
    May 12, 2022

    Pyruvate Dehydrogenase Complex Deficiency Disease Trial in Pittsburgh (No intervention)

    Recruiting
    • Pyruvate Dehydrogenase Complex Deficiency Disease
    • No intervention
    • Pittsburgh, Pennsylvania
      University of Pittsburgh
    Mar 21, 2022

    Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1

    Not yet recruiting
    • Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
    • Ivosidenib 500mg
    • Placebo
    • (no location specified)
    Nov 7, 2023

    Opiod Use Disorder Trial run by the CC (ANS-6637)

    Completed
    Has Results
    • Opiod Use Disorder
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 23, 2020

    Glioblastoma Trial in Belgium, Germany, Netherlands (CV09050101 mRNA vaccine (CVGBM) 12 µg, CV09050101 mRNA vaccine (CVGBM) 25

    Recruiting
    • Glioblastoma
    • CV09050101 mRNA vaccine (CVGBM) 12 μg
    • +5 more
    • Woluwe-Saint-Lambert, Brussels, Belgium
    • +14 more
    Jul 12, 2023

    Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma Trial in Worldwide (AG-120, Placebo)

    Completed
    Has Results
    • Advanced Cholangiocarcinoma
    • Metastatic Cholangiocarcinoma
    • Scottsdale, Arizona
    • +48 more
    Dec 20, 2022

    G6PD Deficiency, Stroke Trial in China (Aspirin, Clopidogrel)

    Recruiting
    • G6PD Deficiency
    • Stroke
    • Longyan, Fujian, China
    • +18 more
    Mar 15, 2022

    Identify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia

    Not yet recruiting
    • Identify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia
    • identify biomarkers
    • (no location specified)
    May 13, 2023

    Brain Tumor, Cancer Trial run by the National Cancer Institute (NCI) (Zotiraciclib)

    Not yet recruiting
    • Brain Tumor
    • Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Vivax Malaria, G6PD Deficiency Trial in Manaus, Porto Velho (Chloroquine, Primaquine)

    Recruiting
    • Vivax Malaria
    • G6PD Deficiency
    • Manaus, Amazonas, Brazil
    • +1 more
    Mar 18, 2022

    Breast Tumor Malignant Female Trial in France, Monaco (DPD activity assessment, Capecitabine)

    Recruiting
    • Breast Neoplasm Malignant Female
    • Cagnes-sur-Mer, France
    • +4 more
    Oct 5, 2021

    Effect of Weight Loss Surgery on Stem Cells.

    Completed
    • Obesity, Morbid
    • +2 more
    • Bariatric (weight loss) surgery
    • Toronto, Ontario, Canada
      St. Michael's Hospital
    Oct 16, 2019

    Glioma Grading and Genotyping

    Recruiting
    • Glioma
      • Chongqing, Chongqing, China
        Sang Zifan
      Aug 29, 2023

      Glioma, Malignant, Computer-Assisted Trial in Shanghai (Validation of IDH1 mutations from the radiomics model)

      Active, not recruiting
      • Glioma, Malignant
      • Computer-Assisted
      • Validation of IDH1 mutations from the radiomics model
      • Shanghai, Shanghai, China
        Huashan Hospital, Fudan University
      Jul 23, 2023

      Study of Prognostic Factors in Adult Lymphoblastic Lymphoma

      Recruiting
      • Lymphoblastic Lymphoma
        • Oviedo, Asturias, Spain
        • +27 more
        Jan 31, 2022

        Glioma, Cholangiocarcinoma, Solid Tumor Trial in Toronto (Olaparib, Durvalumab)

        Recruiting
        • Glioma
        • +3 more
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Nov 29, 2021

        Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia

        Recruiting
        • Acute Myeloid Leukemia
        • +6 more
        • Biospecimen Collection
        • +2 more
        • Orange, California
        • +9 more
        Jan 27, 2023

        Space Occupying Lesions of the Brain

        Recruiting
        • Brain Tumor
        • +2 more
        • MR-scans using a 3T Prisma and a 7T Terra scanner (Siemens, Erlangen Germany)
        • Bern, Switzerland
          Institute for Diagnostic and Interventional Neuroradiology, Univ
        Jan 26, 2023

        Hereditary Neuropathy Caused by SORD Deficiency Trial in Berlin (AT-007, Placebo)

        Recruiting
        • Hereditary Neuropathy Caused by SORD Deficiency
        • Berlin, New Jersey
          Hassman Research Institute
        May 26, 2022

        Cortisol Metabolism in Familial Partial Lipodystrophy Type 2

        Recruiting
        • Familial Partial Lipodystrophy Type 2
        • Biopsy
        • Lille, France
          Hop Claude Huriez
        Jun 20, 2022

        IDH Mutation, IDH1 Mutation, IDH2 Gene Mutation Trial in Chicago (Ivosidenib, Enasidenib, Fedratinib)

        Recruiting
        • IDH Mutation
        • +4 more
        • Chicago, Illinois
          University of Chicago Medical Center
        Nov 12, 2021

        Muscular Fatigue Trial in Maastricht (Olive leaf extract, Placebo)

        Recruiting
        • Muscular Fatigue
        • Olive leaf extract
        • Placebo
        • Maastricht, Netherlands
          Maastricht University Medical Centre +
        Jan 19, 2022

        Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate

        Not yet recruiting
        • Pleural Effusion, Malignant
        • pleural markers
        • (no location specified)
        Jan 20, 2023

        Leukemia Trial in France, United States (BAY2402234)

        Terminated
        • Leukemia
        • Bronx, New York
        • +4 more
        Dec 20, 2021